-
1
-
-
0031975288
-
Depression and the course of coronary artery disease
-
Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
-
(1998)
Am J Psychiatry
, vol.155
, pp. 4-11
-
-
Glassman, A.H.1
Shapiro, P.A.2
-
3
-
-
0028308388
-
Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics
-
Veith RC, Lewis L, Linares OA, Barnes RF, Raskin MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER, Pascualy M, Halter JB: Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994;51:411-422.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 411-422
-
-
Veith, R.C.1
Lewis, L.2
Linares, O.A.3
Barnes, R.F.4
Raskin, Ma.5
Villacres, E.C.6
Murburg, M.M.7
Ashleigh, E.A.8
Castillo, S.9
Peskind, E.R.10
Pascualy, M.11
Halter, J.B.12
-
4
-
-
0014983965
-
Resting plasma catecholamine concentrations in patients with depression and anxiety
-
Wyatt RJ, Portnoy B, Kupfer DJ, Snyder F, Engelman K: Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971;24:65-70.
-
(1971)
Arch Gen Psychiatry
, vol.24
, pp. 65-70
-
-
Wyatt, R.J.1
Portnoy, B.2
Kupfer, D.J.3
Snyder, F.4
Engelman, K.5
-
5
-
-
0029945067
-
Role of catecholamines in platelet function: Pathophysiological and clinical significance
-
Anfossi G, Trovati M: Role of catecholamines in platelet function: Pathophysiological and clinical significance. Eur J Clin Invest 1996;26: 353-370.
-
(1996)
Eur J Clin Invest
, vol.26
, pp. 353-370
-
-
Anfossi, G.1
Trovati, M.2
-
6
-
-
0019827638
-
Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control
-
Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ: Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
-
(1981)
Science
, vol.213
, pp. 220-222
-
-
Akselrod, S.1
Gordon, D.2
Ubel, F.A.3
Shannon, D.C.4
Barger, A.C.5
Cohen, R.J.6
-
7
-
-
0032539749
-
Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells
-
Morin C, Asselin C, Boudreau F, Provencher PH: Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem Biophys Res Commun 1998;244:583-587.
-
(1998)
Biochem Biophys Res Commun
, vol.244
, pp. 583-587
-
-
Morin, C.1
Asselin, C.2
Boudreau, F.3
Provencher, P.H.4
-
8
-
-
0025853502
-
Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells
-
Kanse SM, Takahashi K, Warren JB, Ghatei M, Bloom SR: Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur J Pharmacol 1991;199:99-101.
-
(1991)
Eur J Pharmacol
, vol.199
, pp. 99-101
-
-
Kanse, S.M.1
Takahashi, K.2
Warren, J.B.3
Ghatei, M.4
Bloom, S.R.5
-
9
-
-
0026729512
-
Dexamethasone potentiates production of inositol trisphosphate evoked by endothelin-1 in vascular smooth muscle cells
-
Sato A, Suzuki H, Iwaita Y, Nakazato Y, Kato H, Saruta T: Dexamethasone potentiates production of inositol trisphosphate evoked by endothelin-1 in vascular smooth muscle cells. J Cardiovasc Pharmacol 1992;20:290-295.
-
(1992)
J Cardiovasc Pharmacol
, vol.20
, pp. 290-295
-
-
Sato, A.1
Suzuki, H.2
Iwaita, Y.3
Nakazato, Y.4
Kato, H.5
Saruta, T.6
-
10
-
-
0026730926
-
Dexamethasone down-regulates the expression of endothelin receptors in vascular smooth muscle cells
-
Nambi P, Pullen M, Wu HL, Nuthulaganti P, Elshourbagy N, Kumar C: Dexamethasone down-regulates the expression of endothelin receptors in vascular smooth muscle cells. J Biol Chem 1992;267:19555-19559.
-
(1992)
J Biol Chem
, vol.267
, pp. 19555-19559
-
-
Nambi, P.1
Pullen, M.2
Wu, H.L.3
Nuthulaganti, P.4
Elshourbagy, N.5
Kumar, C.6
-
11
-
-
0028960689
-
Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells
-
Provencher PH, Saltis J, Funder JW: Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J Steroid Biochem Mol Biol 1995;52:219-225.
-
(1995)
J Steroid Biochem Mol Biol
, vol.52
, pp. 219-225
-
-
Provencher, P.H.1
Saltis, J.2
Funder, J.W.3
-
12
-
-
0023859136
-
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
-
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
-
(1988)
Nature
, vol.332
, pp. 411-415
-
-
Yanagisawa, M.1
Kurihara, H.2
Kimura, S.3
Tomobe, Y.4
Kobayashi, M.5
Mitsui, Y.6
Yazaki, Y.7
Goto, K.8
Masaki, T.9
-
13
-
-
0025057374
-
Increased plasma endothelin level in patients with essential hypertension
-
Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;322:205.
-
(1990)
N Engl J Med
, vol.322
, pp. 205
-
-
Saito, Y.1
Nakao, K.2
Mukoyama, M.3
Imura, H.4
-
14
-
-
0028204079
-
Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
-
Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K: Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89:1573-1579.
-
(1994)
Circulation
, vol.89
, pp. 1573-1579
-
-
Omland, T.1
Lie, R.T.2
Aakvaag, A.3
Aarsland, T.4
Dickstein, K.5
-
16
-
-
0024840314
-
Endothelin concentrations in cerebrospinal fluid in depressive patients
-
Hoffman A, Keiser HR, Grossman E, Goldstein DS, Gold PW, Kling M: Endothelin concentrations in cerebrospinal fluid in depressive patients. Lancet 1989;23:1519.
-
(1989)
Lancet
, vol.23
, pp. 1519
-
-
Hoffman, A.1
Keiser, H.R.2
Grossman, E.3
Goldstein, D.S.4
Gold, P.W.5
Kling, M.6
|